Literature DB >> 7609025

The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.

Z Tu1, N M Chapman, G Hufnagel, S Tracy, J R Romero, W H Barry, L Zhao, K Currey, B Shapiro.   

Abstract

We report the construction of chimeric coxsackievirus B3 (CVB3) strains in which sequences of an infectious cDNA copy of a noncardiovirulent CVB3 genome were replaced by the homologous sequences from a cardiovirulent CVB3 genome to identify which of 10 predicted genetic sites determine cardiovirulence. Cardiovirulent phenotype expression was consistently linked to nucleotide 234 (U in cardiovirulent CVB3 and C in avirulent CVB3) in the 5' nontranslated region. Reconstructions of the parental noncardiovirulent CVB3 genome from chimeras restored the noncardiovirulent phenotype when tested in mice. Inoculation of severe combined immunodeficient (scid) mice with the noncardiovirulent CVB3 strain resulted in massive cardiomyocyte necrosis in all animals. Sequence analysis of viral genomes isolated from twelve scid mouse hearts showed that only nucleotide position 234 was different (a C-->U transition) from that in the input parental noncardiovirulent CVB3 genome. Higher-order RNA structures predicted by two different algorithms did not demonstrate an obvious local effect caused by the C-->U change at nucleotide 234. Initial studies of parental and chimeric CVB3 replication in primary cultures of fetal murine heart fibroblasts and in adult murine cardiac myocytes demonstrated that viral RNA transcriptional efficiency is approximately 10-fold lower for noncardiovirulent CVB3 than for cardiovirulent CVB3. CVB3 did not shut off protein synthesis in murine cardiac fibroblasts, nor were levels of viral protein synthesis significantly different as a function of viral phenotype. Taken together, these data support a significant role for determination of the CVB3 cardiovirulence phenotype by nucleotide 234 in the 5' nontranslated region, possibly via a transcriptional mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609025      PMCID: PMC189260          DOI: 10.1128/JVI.69.8.4607-4618.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  89 in total

1.  Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3.

Authors:  A M Lindberg; R L Crowell; R Zell; R Kandolf; U Pettersson
Journal:  Virus Res       Date:  1992-07       Impact factor: 3.303

2.  Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5' noncoding region.

Authors:  J R Gebhard; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop.

Authors:  T A Manolio; K L Baughman; R Rodeheffer; T A Pearson; J D Bristow; V V Michels; W H Abelmann; W R Harlan
Journal:  Am J Cardiol       Date:  1992-06-01       Impact factor: 2.778

4.  Conservation of RNA-protein interactions among picornaviruses.

Authors:  S L Dildine; B L Semler
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

5.  Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture.

Authors:  A J Macadam; G Ferguson; J Burlison; D Stone; R Skuce; J W Almond; P D Minor
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

6.  Optimization of the polymerase chain reaction with regard to fidelity: modified T7, Taq, and vent DNA polymerases.

Authors:  L L Ling; P Keohavong; C Dias; W G Thilly
Journal:  PCR Methods Appl       Date:  1991-08

7.  A cellular protein that binds to the 5'-noncoding region of poliovirus RNA: implications for internal translation initiation.

Authors:  K Meerovitch; J Pelletier; N Sonenberg
Journal:  Genes Dev       Date:  1989-07       Impact factor: 11.361

8.  Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s).

Authors:  M A Beck; S M Tracy
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Interesting problems in enteroviral inflammatory heart disease.

Authors:  S Tracy; G Hufnagel; N Chapman
Journal:  Herz       Date:  1992-04       Impact factor: 1.443

10.  Conserved tertiary structure elements in the 5' untranslated region of human enteroviruses and rhinoviruses.

Authors:  S Y Le; J H Chen; N Sonenberg; J V Maizel
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

View more
  58 in total

1.  Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density.

Authors:  S D Carson; J T Hobbs; S M Tracy; N M Chapman
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus.

Authors:  T Kanno; D Mackay; T Inoue; G Wilsden; M Yamakawa; R Yamazoe; S Yamaguchi; J Shirai; P Kitching; Y Murakami
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

Authors:  N M Chapman; K S Kim; S Tracy; J Jackson; K Höfling; J S Leser; J Malone; P Kolbeck
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.

Authors:  Steven D Carson; Nora M Chapman; Susan Hafenstein; Steven Tracy
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 5.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

6.  Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein.

Authors:  A I Ramsingh; W T Lee; D N Collins; L E Armstrong
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.

Authors:  Nadia Jrad-Battikh; Amira Souii; Leila Oueslati; Mahjoub Aouni; Didier Hober; Jawhar Gharbi; Manel Ben M'hadheb-Gharbi
Journal:  Curr Microbiol       Date:  2013-12-10       Impact factor: 2.188

8.  Coxsackievirus B3 infection and its mutation in Keshan disease.

Authors:  Li-Qun Ren; Xiang-Jun Li; Guang-Sheng Li; Zhi-Tao Zhao; Bo Sun; Fei Sun
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

9.  Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis.

Authors:  Jennifer M Bailey; William E Tapprich
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

10.  Progression or resolution of coxsackievirus B4-induced pancreatitis: a genomic analysis.

Authors:  Stephanie E Ostrowski; Andrew A Reilly; Doris N Collins; Arlene I Ramsingh
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.